Prochymal- 8 Million cells/kg not checked

Mesoblast, Inc.

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“8 million hMSCs/kg actual body weight IV on study Days 1 and 4”In the company’s words, NCT00136903 on ClinicalTrials.gov
Tested for
Graft Vs Host Disease
Main trialPhase 2
“To establish the safety and efficacy of two dose levels of ex-vivo cultured adult human mesenchymal stem cells (hMSCs) (Prochymal®) in participants experiencing acute GVHD, Grades II-IV, post hematopoietic stem cells (HSC) transplant.”In the company’s words, NCT00136903 on ClinicalTrials.gov
Other names
Remestemcel-L · hMSCs

Other drugs for Graft Vs Host Disease

All 24 drugs for Graft Vs Host Disease

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Completed 28 Jul 2006 Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Prochymal- 8 Million cells/kg

Following is part of Solo: you see every change to Prochymal- 8 Million cells/kg the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in